Dont underestimate the many strings to Primas bow.
It should be remembered that Primas technology will apply to a multitude of different cancers, significantly enhancing its appeal to both investors and potential takeover suitors.
Added to that is the oral delivery system for gardasil, which I believe, is not factored in or valued highly enough by some analysts and investors. IMO, this will add SIGNIFICANTLY to Primas revenue stream, and put it way ahead of the pack amongst its peers.
Like I have said for years...the calibre of personel involved with Prima Biomed would simply not be there risking reward and reputation if there was not a very very strong chance of success!
dndn, page-3
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.005(1.59%) |
Mkt cap ! $450.9M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 32.0¢ | 30.5¢ | $922.9K | 2.963M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 149460 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |